0000000000105841

AUTHOR

Víctor Manuel Becerra-muñoz

showing 9 related works from this author

Underlying heart diseases and acute COVID-19 outcomes

2021

Background: The presence of any underlying heart condition could influence outcomes during the coronavirus disease 2019 (COVID-19). Methods: The registry HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19, NCT04334291) is an international ambispective study, enrolling COVID-19 patients discharged from hospital, dead or alive. Results: HOPE enrolled 2798 patients from 35 centers in 7 countries. Median age was 67 years (IQR: 53.0-78.0), and most were male (59.5%). A relevant heart disease was present in 682 (24%) cases. These were older, more frequently male, with higher overall burden of cardiovascular risk factors (hypertension, dyslipidemia, diabetes mellitus, smoking habit, …

Malemedicine.medical_specialtyHeart DiseasesHeart diseaseInfecciones por coronavirusEnfermedad cardiovascularEnfermedad transmisibleheart diseaseComorbidityregistry030204 cardiovascular system & hematologyGlobal HealthSepsis03 medical and health scienceschemistry.chemical_compound0302 clinical medicineTocilizumabRisk FactorsDiabetes mellitusInternal medicinemedicineHumansRegistriesPandemicsAgedRetrospective StudiesSARS-CoV-2business.industryCOVID-19HydroxychloroquineGeneral MedicineMiddle AgedPrognosismedicine.diseasemortalitychemistrycardiologyHeart failureCohortCardiologyFemaleCardiology and Cardiovascular MedicinebusinessDyslipidemiamedicine.drugCardiology Journal
researchProduct

Prognostic role of tapse to pasp ratio in patients undergoing mitraclip procedure

2021

Producción Científica

medicine.medical_specialtyTransthoracic echocardiographyCorazón - Cirugíamedicine.medical_treatmentCardiology3205.01 Cardiologíalcsh:MedicineHeart valves - Diseases - diagnostic imaging030204 cardiovascular system & hematologyRight ventricular to pulmonary arterial couplingArticlePulmonary hypertension03 medical and health sciencesmitral valve repairtransthoracic echocardiography0302 clinical medicineInternal medicinepulmonary hypertensionmedicineMitraClipCorazón - Enfermedades030212 general & internal medicineMitral valve repairMitral regurgitationMitral valve - Diseases - ImagingProportional hazards modelbusiness.industryMitraClipmitral valve regurgitationlcsh:RGeneral MedicineCardiac surgerymedicine.disease3207.04 Patología CardiovascularPulmonary hypertensionHipertensión pulmonarBlood pressureEchocardiographyHeart failureCardiologyright ventricular to pulmonary arterial couplingHeart - DiseasesMitral valve regurgitationbusinessMitral valve repairMitral valve regurgitation
researchProduct

Impact of smoking on COVID-19 outcomes: a HOPE Registry subanalysis

2021

BackgroundSmoking has been associated with poorer outcomes in relation to COVID-19. Smokers have higher risk of mortality and have a more severe clinical course. There is paucity of data available on this issue, and a definitive link between smoking and COVID-19 prognosis has yet to be established.MethodsWe included 5224 patients with COVID-19 with an available smoking history in a multicentre international registry Health Outcome Predictive Evaluation for COVID-19 (NCT04334291). Patients were included following an in-hospital admission with a COVID-19 diagnosis. We analysed the outcomes of patients with a current or prior history of smoking compared with the non-smoking group. The primary …

2474medicine.medical_specialtyRC620-627Health (social science)Coronavirus disease 2019 (COVID-19)infectious diseaseMedicine (miscellaneous)Health outcomesSepsis03 medical and health sciences0302 clinical medicineInternal medicinemedicineClinical endpointRisk of mortality1506030212 general & internal medicineNutritional diseases. Deficiency diseasesOriginal Researchpulmonary diseaseNutrition and Dieteticsbusiness.industry2524Clinical courseCOVID-19medicine.diseaseFormer Smoker030228 respiratory systemSmoking statusbusinessBMJ Nutrition, Prevention & Health
researchProduct

Clinical and echocardiographic outcomes of transcatheter mitral valve repair in atrial functional mitral regurgitation.

2021

Background: Isolated atrial fibrillation can cause mitral regurgitation (MR) in patients with normal left ventricular systolic function and no organic disease of the mitral valve. Little information is available regarding outcomes of Mitraclip in patients with atrial functional mitral regurgitation (AFMR). We aimed to evaluate 12-month clinical and echocardiographic outcomes of transcatheter mitral valve repair (TMVR) with MitraClip in patients with AFMR compared to those with ventricular functional or degenerative/mixed MR. Methods: Registry-based analysis of all consecutive patients who underwent TMVR and were included in the Spanish Registry of Mitraclip. Changes in MR and NYHA functiona…

MaleAtrial mitral regurgitation Functional mitral regurgitation MitraClipmedicine.medical_specialtyCardiac CatheterizationOrganic diseaseInternal medicineMitral valvemedicineMitraClipHumansHeart Atriacardiovascular diseasesAtrial mitral regurgitationFunctional mitral regurgitationAgedAged 80 and overHeart Valve Prosthesis ImplantationMitral regurgitationbusiness.industryMitraClipMitral Valve InsufficiencyAtrial fibrillationMiddle Agedmedicine.diseasemedicine.anatomical_structureTreatment OutcomeFunctional mitral regurgitationEchocardiographyHeart failureCardiologycardiovascular systemMitral ValveTranscatheter mitral valve repairFemaleCardiology and Cardiovascular Medicinebusiness
researchProduct

Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 …

2021

Background The use of Renin-Angiotensin system inhibitors (RASi) in patients with coronavirus disease 2019 (COVID-19) has been questioned because both share a target receptor site. Methods HOPE-COVID-19 (NCT04334291) is an international investigator-initiated registry. Patients are eligible when discharged after an in-hospital stay with COVID-19, dead or alive. Here, we analyze the impact of previous and continued in-hospital treatment with RASi in all-cause mortality and the development of in-stay complications. Results We included 6503 patients, over 18 years, from Spain and Italy with data on their RASi status. Of those, 36.8% were receiving any RASi before admission. RASi patients were …

QA75Malemedicine.medical_specialtyHeart diseaseInfecciones por coronavirusmedicine.medical_treatmentInhibidores enzimáticosPopulationClinical InvestigationsEnfermedad transmisibleAngiotensin-Converting Enzyme InhibitorsSistema renina-angiotensinaComorbidity030204 cardiovascular system & hematologySeverity of Illness Index03 medical and health sciences0302 clinical medicineRisk FactorsOutcome Assessment Health CareSeverity of illnessmedicineHumansRegistries030212 general & internal medicineMedical prescriptioneducationHeart FailureMechanical ventilationeducation.field_of_studySARS-CoV-2business.industryCOVID-19Middle AgedPrognosismedicine.diseaseR1Respiration ArtificialComorbidityHospitalizationItalySpainHeart failureEmergency medicineFemaleObservational studyCardiology and Cardiovascular MedicinebusinessAmerican Heart Journal
researchProduct

Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19.

2020

Abstract Background the coronavirus disease 2019 (COVID-19) is characterized by poor outcomes and mortality, particularly in older patients. Methods post hoc analysis of the international, multicentre, ‘real-world’ HOPE COVID-19 registry. All patients aged ≥65 years hospitalised for COVID-19 were selected. Epidemiological, clinical, analytical and outcome data were obtained. A comparative study between two age subgroups, 65–74 and ≥75 years, was performed. The primary endpoint was all cause in-hospital mortality. Results about, 1,520 patients aged ≥65 years (60.3% male, median age of 76 [IQR 71–83] years) were included. Comorbidities such as hypertension (69.2%), dyslipidaemia (48.6%), card…

MaleAgingmedicine.medical_specialtyInternational CooperationPopulation030204 cardiovascular system & hematologycomorbiditiesRisk Assessment03 medical and health sciencesAcademicSubjects/MED002800302 clinical medicineRisk FactorsInternal medicineEpidemiologymedicineClinical endpointDementiaHumans030212 general & internal medicineHospital MortalityRegistriesMortalityeducationGeriatric Assessmentolder adultsAgedAged 80 and overeducation.field_of_studyCoronavirus disease 2019business.industrySARS-CoV-2COVID-19MultimorbidityGeneral Medicinemedicine.diseasePrognosisComorbidityHospitalizationAgeingIntensive Care UnitsRespiratory failureHeart failureFemaleGeriatrics and GerontologybusinessDyslipidemiaResearch PaperAge and ageing
researchProduct

Transcatheter Mitral Repair for Functional Mitral Regurgitation According to Left Ventricular Function: A Real-Life Propensity-Score Matched Study

2020

Background: Transcatheter mitral valve repair (TMVR) could improve survival in functional mitral regurgitation (FMR), but it is necessary to consider the influence of left ventricular ejection fraction (LVEF). Therefore, we compare the outcomes after TMVR with Mitraclip&reg

medicine.medical_specialtylcsh:Medicine030204 cardiovascular system & hematologyMitraclipArticle03 medical and health sciences0302 clinical medicineInternal medicinemedicineIn patient030212 general & internal medicinecardiovascular diseasesFunctional mitral regurgitationEjection fractionVentricular functionbusiness.industryMitraCliplcsh:RGeneral Medicinetranscatheterleft ventricular ejection FractionPropensity score matchingCardiologycardiovascular systemObservational studyTranscatheter mitral valve repairbusinesscirculatory and respiratory physiologyfunctional mitral regurgitationJournal of Clinical Medicine
researchProduct

Gender Differences in the Presentation and Outcomes of Hospitalized Patients With COVID-19

2021

Gender-related differences in COVID-19 clinical presentation, disease progression, and mortality have not been adequately explored. We analyzed the clinical profile, presentation, treatments, and outcomes of patients according to gender in the HOPE-COVID-19 International Registry. Among 2,798 enrolled patients, 1,111 were women (39.7%). Male patients had a higher prevalence of cardiovascular risk factors and more comorbidities at baseline. After propensity score matching, 876 men and 876 women were selected. Male patients more often reported fever, whereas female patients more often reported vomiting, diarrhea, and hyposmia/anosmia. Laboratory tests in men presented alterations consistent w…

Malemedicine.medical_specialtyLeadership and ManagementAnosmiaComorbidityAssessment and DiagnosisCohort Studies03 medical and health sciencesSex Factors0302 clinical medicineHyposmiaInternal medicinemedicineHumans030212 general & internal medicine030223 otorhinolaryngologyCare PlanningAgedAged 80 and overbusiness.industryHealth PolicyCOVID-19General MedicineMiddle Agedmedicine.diseaseComorbidityHospitalizationSystemic inflammatory response syndromeHeart Disease Risk FactorsPropensity score matchingDisease ProgressionVomitingFemaleFundamentals and skillsmedicine.symptomLymphocytopeniabusinessCohort studyJournal of Hospital Medicine
researchProduct

Predictors of poor prognosis in healthy, young, individuals with SARS-CoV-2 infections.

2021

OBJECTIVES: To identify predictors of poor prognosis in previously healthy young individuals admitted with COVID-19. METHODS: We studied a cohort of patients hospitalized with COVID-19 disease. All patients without comorbidities, no usual treatments and =65years old were selected from an international registry (HOPE-COVID-19, NCT04334291). We focused on baseline variables-symptoms and signs at admission-to analyze risk factors for poor prognosis. The primary endpoint was a composite of major adverse clinical events during hospitalization including mortality, mechanical ventilation, high flow nasal oxygen therapy, prone, sepsis, SIRS, and embolic events. RESULTS: Overall, 773 healthy young p…

Microbiology (medical)AdultMalemedicine.medical_specialtymedicine.medical_treatmentYoungSepsisInternal medicineOxygen therapymedicineClinical endpointHumansMortalityRespiratory systemAgedRetrospective StudiesMechanical ventilationHealthybusiness.industrySARS-CoV-2Mortality rateCOVID-19General MedicineMiddle Agedmedicine.diseasePrognosisRespiration ArtificialSystemic inflammatory response syndromeHospitalizationInfectious DiseasesLung diseaseCohortOriginal ArticlebusinessRespiratory InsufficiencyClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
researchProduct